Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

[E. Helskog and colleagues reply].

Helskog E, Bjartveit K.

Tidsskr Nor Laegeforen. 2014 May 27;134(10):1023. doi: 10.4045/tidsskr.14.0609. eCollection 2014 May 27. Norwegian. No abstract available.

2.

[E.H. Helskog and colleagues reply].

Helskog EH, Bjartveit K.

Tidsskr Nor Laegeforen. 2014 Apr 8;134(7):691. doi: 10.4045/tidsskr.14.0368. eCollection 2014 Apr 8. Norwegian. No abstract available.

3.

[Woman in her 30s with chronic fatigue].

Bjartveit K, Helskog EH, Kryvi PD, Brauer H.

Tidsskr Nor Laegeforen. 2014 Feb 25;134(4):423-5. doi: 10.4045/tidsskr.13.0142. Norwegian. No abstract available.

4.

Health consequences of pipe versus cigarette smoking.

Tverdal A, Bjartveit K.

Tob Control. 2011 Mar;20(2):123-30. doi: 10.1136/tc.2010.036780. Epub 2010 Oct 15.

PMID:
20952559
5.

[Internment and release].

Bjartveit K.

Tidsskr Nor Laegeforen. 2009 May 14;129(10):1007-8. doi: 10.4045/tidsskr.09.0485. Norwegian. No abstract available.

6.

Health consequences of sustained smoking cessation.

Bjartveit K, Tverdal A.

Tob Control. 2009 Jun;18(3):197-205. doi: 10.1136/tc.2008.026898. Epub 2009 Feb 18.

PMID:
19228666
7.

Health consequences of reduced daily cigarette consumption.

Tverdal A, Bjartveit K.

Tob Control. 2006 Dec;15(6):472-80.

8.

Health consequences of smoking 1-4 cigarettes per day: response to G F Cope (eletter to journal).

Bjartveit K, Tverdal A.

Tob Control. 2006 Feb;15(1):71-2. No abstract available.

9.

Health consequences of smoking 1-4 cigarettes per day.

Bjartveit K, Tverdal A.

Tob Control. 2005 Oct;14(5):315-20.

10.
11.

[All information about preparations is on the Medical Products Agency's web-site].

Bjartveit K, Halse H, Madsen S, Vollset I, Wesenberg GR.

Tidsskr Nor Laegeforen. 2002 Dec 10;122(30):2923-4. Norwegian. No abstract available.

PMID:
12569724
12.

[Olaf Scheel and Johannes Heimbeck and their work with the BCG vaccine].

Bjartveit K.

Tidsskr Nor Laegeforen. 2001 Mar 30;121(9):1076-81. Norwegian.

13.

A comparison of a non-ionic dimer, iodixanol with a non-ionic monomer, iohexol in low dose intravenous urography.

Skehan SJ, Rasmussen F, Gibney RG, Lindequist S, Moller-Nielsen S, Svaland MG, Kampenes VB, Bjartveit K, Greaney T, Carlsen SD, Masterson J.

Br J Radiol. 1998 Sep;71(849):910-7.

PMID:
10195003
14.

Diagnostic quality in hysterosalpingography. Comparison between iodixanol and iotrolan.

Lindequist S, Rasmussen F, Madsen HH, Naeser A, Bjartveit K, Kristoffersen DT, Klaveness AJ.

Acta Radiol. 1998 Nov;39(6):730-3.

PMID:
9817052
15.

Ex-smokers and risk of hip fracture.

Forsén L, Bjartveit K, Bjørndal A, Edna TH, Meyer HE, Schei B.

Am J Public Health. 1998 Oct;88(10):1481-3.

16.

The history of the Norwegian ban on tobacco advertising.

Bjartveit K.

Clio Med. 1998;46:216-9; discussion 220. No abstract available.

PMID:
9607159
17.

[Cardiovascular risk factors in Oslo, Sogn and Fjordane and Finnmark. Study of 40-year old subjects in Oslo 1981-88].

Jenum AK, Stensvold I, Bjartveit K, Thelle DS, Hjermann I.

Tidsskr Nor Laegeforen. 1998 Jan 10;118(1):18-22. Norwegian.

PMID:
9481904
20.

Renal CT after intravenous injection of nonionic dimeric or nonionic monomeric contrast media in healthy volunteers.

Rasmussen F, Lindequist S, Nielsen SM, Bjartveit K.

Acta Radiol. 1997 Jan;38(1):61-7.

PMID:
9059403
21.

[Tuberculosis trends in Norway--has the decline stopped?].

Heldal E, Bjartveit K, Tverdal A.

Tidsskr Nor Laegeforen. 1995 Nov 10;115(27):3390-3. Norwegian.

PMID:
7491584
23.

Interaction between current smoking, leanness, and physical inactivity in the prediction of hip fracture.

Forsén L, Bjørndal A, Bjartveit K, Edna TH, Holmen J, Jessen V, Westberg G.

J Bone Miner Res. 1994 Nov;9(11):1671-8.

PMID:
7863817
24.

Iodixanol in intravenous urography: a comparison of iodixanol 270 mgI/ml, iodixanol 320 mgI/ml and iopamidol 300 mgI/ml (NIOPAM).

Conroy RM, Bjartveit K, Sheppick A, Long U, Masterson J.

Clin Radiol. 1994 May;49(5):337-40.

PMID:
8013200
25.

Mortality in relation to smoking history: 13 years' follow-up of 68,000 Norwegian men and women 35-49 years.

Tverdal A, Thelle D, Stensvold I, Leren P, Bjartveit K.

J Clin Epidemiol. 1993 May;46(5):475-87.

PMID:
8501474
26.

[Cardiovascular screenings in Norwegian counties. Trends in risk pattern during the period 1985-90 among persons aged 40-42 in 4 counties].

Bjartveit K, Stensvold I, Lund-Larsen PG, Graff-Iversen S, Urdal P.

Tidsskr Nor Laegeforen. 1991 Jun 30;111(17):2072-6. Norwegian.

PMID:
1871735
27.

[Cardiovascular screenings in Norwegian counties. Background and implementation. Status of risk pattern during the period 1986-90 among persons aged 40-42 years in 14 counties].

Bjartveit K, Stensvold I, Lund-Larsen PG, Gjervig T, Krüger O, Urdal P.

Tidsskr Nor Laegeforen. 1991 Jun 30;111(17):2063-72. Norwegian.

PMID:
1871734
28.

[Smoking and health attitudes in Norway].

Bjartveit K.

Tidsskr Nor Laegeforen. 1990 Aug 10;110(18):2395-8. Norwegian. No abstract available.

PMID:
2219005
29.

Coffee consumption and death from coronary heart disease in middle aged Norwegian men and women.

Tverdal A, Stensvold I, Solvoll K, Foss OP, Lund-Larsen P, Bjartveit K.

BMJ. 1990 Mar 3;300(6724):566-9.

30.

[The tobacco epidemic can be stopped].

Bjartveit K, Thürmer H, Nylenna M.

Tidsskr Nor Laegeforen. 1990 Jan 10;110(1):16-8. Norwegian. No abstract available.

PMID:
2300927
31.

Smoking as a risk factor for chronic airways disease.

Crofton J, Bjartveit K.

Chest. 1989 Sep;96(3 Suppl):307S-312S. No abstract available.

PMID:
2766850
32.

Serum triglycerides as an independent risk factor for death from coronary heart disease in middle-aged Norwegian men.

Tverdal A, Foss OP, Leren P, Holme I, Lund-Larsen PG, Bjartveit K.

Am J Epidemiol. 1989 Mar;129(3):458-65.

PMID:
2916539
33.

[Treatment of hypercholesterolemia in adults. An action plan].

Bjartveit K, Blomhoff JP, Drevon CA, Gjone E, Hjermann I, Holm HA, Kjekshus J, Levorsen A, Norum KR, Nylenna M, et al.

Tidsskr Nor Laegeforen. 1988 Sep 30;108(27):2285-8. Norwegian. No abstract available.

PMID:
3206437
34.

Children--in the midst of a battlefield.

Bjartveit K.

Bull Int Union Tuberc Lung Dis. 1988 Jun;63(2):45-6. Review. No abstract available.

PMID:
3066421
35.

[Cardiovascular program in Oppland County and Sogn and Fjordane. A summary of ideas and organization].

Aarø LE, Karlsen E, Vaa T, Stenmarck S, Bjartveit K, Hjort PF.

Tidsskr Nor Laegeforen. 1987 Oct 10;107(28):2410-4. Norwegian. No abstract available.

PMID:
3686490
36.

[Prevent coronary heart disease. A summary from a joint report of the European Society of Atherosclerosis with Norwegian comments].

Bjartveit K, Norum K, Thelle DS.

Tidsskr Nor Laegeforen. 1987 May 20;107(14):1238-40. Norwegian. No abstract available.

PMID:
3603489
37.

Notification of tuberculosis in the south-west health region of Norway: incidence and trends.

Gulsvik A, Tverdal A, Risan E, Holm AM, Jentoft HF, Bjartveit K.

Br J Dis Chest. 1987 Apr;81(2):140-6.

PMID:
3651307
38.

[Smoking habits of Norwegian doctors 1952-84].

Thürmer H, Bjartveit K, Hauknes A.

Tidsskr Nor Laegeforen. 1986 Dec 10;106(34-36):2961-4. Norwegian. No abstract available.

PMID:
3810617
39.
40.

Smoking control implementation. Legislation and political activity.

Bjartveit K.

IARC Sci Publ. 1986;(74):285-98. No abstract available.

PMID:
3623670
41.
42.

The cardiovascular disease study in Norwegian counties. Results from first screening.

Bjartveit K, Foss OP, Gjervig T.

Acta Med Scand Suppl. 1983;675:1-184. No abstract available.

PMID:
6581684
43.

Controlling the epidemic: legislation and restrictive measures.

Bjartveit K, Lochsen PM, Aaro LE.

Can J Public Health. 1981 Nov-Dec;72(6):406-12. No abstract available.

PMID:
7337896
44.

[Side effects of antitubercular drugs leading to discontinuation of drug therapy].

Bergan S, Laake K, Bjartveit K.

Tidsskr Nor Laegeforen. 1980 Feb 20;100(5):279-82. Norwegian. No abstract available.

PMID:
7385151
45.

The cardiovascular disease study in Norwegian counties. Background and organization.

Bjartveit K, Foss OP, Gjervig T, Lund-Larsen PG.

Acta Med Scand Suppl. 1979;634:1-70. No abstract available.

PMID:
293122
46.

[Governmental action on smoking and health].

Bjartveit K.

Bull Int Union Tuberc. 1978 Dec;53(4):353-8. French. No abstract available.

PMID:
756313
47.

Tuberculosis situation in the Scandinavian countries.

Christensen O, Bjartveit K, Dahlström G.

Scand J Respir Dis Suppl. 1978;102:19-40. No abstract available.

PMID:
278204
48.

The Norwegian tobacco act. (Introduction).

Bjartveit K.

Scand J Respir Dis Suppl. 1978;102:142-6. No abstract available.

PMID:
278188
49.

Smoking habits among Norwegian doctors 1974.

Aaro LE, Bjartveit K, Vellar OD, Berglund EL.

Scand J Soc Med. 1977;5(3):127-35.

PMID:
594707
50.

[The Tobacco Act in Norway--experiences in its enforcement].

Bjartveit K.

Nord Med. 1976 Sep;91(8-9):224-6. Norwegian. No abstract available.

PMID:
967649

Supplemental Content

Loading ...
Support Center